Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Do We Have a Vanquishing New Strategy?

European Journal of Preventive Cardiology - United Kingdom
doi 10.1177/2047487318817671
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications


Related search